Latest Articles
China-led team replicates human embryo ‘invasion’ of the womb for the first time - South China Morning Post
China-led team replicates human embryo ‘invasion’ of the womb for the first time South China Morning Post
Published: Jan. 10, 2026, 4 a.m.
Cell map offers insights into endometrial dysfunction in women with PCOS - MSN
Cell map offers insights into endometrial dysfunction in women with PCOS MSN
Published: Jan. 10, 2026, 2:52 a.m.
I spent £10,000 to treat my endometriosis – we don’t need more NHS hurdles - MSN
I spent £10,000 to treat my endometriosis – we don’t need more NHS hurdles MSN
Published: Jan. 9, 2026, 5:35 p.m.
New DNA Sequence Motifs Identified as Regulators of Gene Expression in T Cells - geneonline.com
New DNA Sequence Motifs Identified as Regulators of Gene Expression in T Cells geneonline.com
Published: Jan. 9, 2026, 3:41 p.m.
Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data - Investing.com UK
Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data Investing.com UK
Published: Jan. 9, 2026, 2:25 p.m.
Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data - Investing.com
Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data Investing.com
Published: Jan. 9, 2026, 1:59 p.m.
‘Misinformation spreads fast via personal stories’: Appraising the rise of Reddit for health advice - Women's Health
‘Misinformation spreads fast via personal stories’: Appraising the rise of Reddit for health advice Women's Health
Published: Jan. 9, 2026, 12:51 p.m.
Endometriosis Treatment Market Forecast to Grow to USD 3.37 - openPR.com
Endometriosis Treatment Market Forecast to Grow to USD 3.37 openPR.com
Published: Jan. 9, 2026, 10:57 a.m.
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 - Sahm
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 …
Published: Jan. 9, 2026, 6:18 a.m.
Is LENZ stock a defensive play in 2025 - July 2025 Fed Impact & Consistent Growth Equity Picks - ulpravda.ru
Is LENZ stock a defensive play in 2025 - July 2025 Fed Impact & Consistent Growth Equity Picks ulpravda.ru
Published: Jan. 9, 2026, 5:21 a.m.
Link copied to clipboard!